Results 171 to 180 of about 63,671 (294)

CT‐P39 Compared With Reference Omalizumab in Chronic Spontaneous Urticaria: Results From a Double‐Blind, Randomized, Active‐Controlled, Phase 3 Study

open access: yesAllergy, EarlyView.
This study investigated the therapeutic equivalence of CT‐P39 (an omalizumab biosimilar) and EU‐approved reference omalizumab (ref‐OMA) in patients with chronic spontaneous urticaria. Therapeutic equivalence between CT‐P39 and ref‑OMA (300 mg) was demonstrated by the primary endpoint – confidence intervals of the treatment difference in mean change ...
Sarbjit S. Saini   +16 more
wiley   +1 more source

Effective treatment of canine chronic cutaneous lupus erythematosus variants with oclacitinib: Seven cases

open access: yesVeterinary Dermatology, Volume 34, Issue 1, Page 53-58, February 2023., 2023
Background – The treatment of canine chronic cutaneous lupus erythematosus (CCLE) variants generally requires immunosuppression, which often results in potentially severe adverse effects. Janus kinase inhibitors, like oclacitinib, might be a valuable treatment option due to their rapid inhibition of the action of interferons known to be relevant in the
Richard G. Harvey   +3 more
wiley   +1 more source

Infliximab-induced autoimmune-like hepatitis in a patient with Crohn's disease: a case report. [PDF]

open access: yesFuture Sci OA
Ayadi S   +7 more
europepmc   +1 more source

Juvenile idiopathic arthritis during 20 years in Sweden: Characteristics of children, therapy interventions, occurrence of uveitis and ocular complications

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose To assess and compare the characteristics, therapy interventions, occurrence of uveitis and ocular complications in children with juvenile idiopathic arthritis (JIA) screened and examined for uveitis in Gothenburg, Sweden, over 20 years.
Pia Lundgren   +7 more
wiley   +1 more source

A controlled trial of azathioprine in the treatment of pemphigoid

open access: bronze, 1978
J.L. Burton   +3 more
openalex   +1 more source

OpenSAFELY: The impact of COVID‐19 on azathioprine, leflunomide and methotrexate monitoring, and factors associated with change in monitoring rate

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims The COVID‐19 pandemic created unprecedented pressure on healthcare services. This study investigates whether disease‐modifying antirheumatic drug (DMARD) safety monitoring was affected during the COVID‐19 pandemic. Methods A population‐based cohort study was conducted using the OpenSAFELY platform to access electronic health record data from 24.2 ...
Andrew D. Brown   +27 more
wiley   +1 more source

Therapeutic drug monitoring of tacrolimus after kidney transplantation: trough concentration or area under curve‐based monitoring?

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Measurement of pre‐dose tacrolimus concentrations, also referred to as trough concentrations or C0 (in this paper the term C0 will be used), is the most frequently used parameter for therapeutic drug monitoring in patients after solid organ transplantation. C0 is relatively easy to obtain, and can be combined with other lab tests.
Teun van Gelder   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy